Boehringer Ingelheim (Canada) Ltd./Ltée. Sustainability Profile
Boehringer Ingelheim (Canada) Ltd./Ltée., a subsidiary of the global pharmaceutical giant Boehringer Ingelheim, is headquartered in Canada and operates extensively across the country. Founded in 1885, the company has established itself as a leader in the pharmaceutical industry, focusing on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. With a commitment to innovation, Boehringer Ingelheim offers a diverse range of core products and services, including prescription medications and vaccines that address critical health challenges. The company is renowned for its research-driven approach, which has led to significant advancements in therapeutic areas such as respiratory diseases, oncology, and diabetes care. Boehringer Ingelheim's strong market position is underscored by its dedication to improving patient outcomes and its notable achievements in developing unique therapies that enhance quality of life. As a trusted name in healthcare, the company continues to make impactful contributions to both human and animal health sectors.
DitchCarbon Score
How does Boehringer Ingelheim (Canada) Ltd./Ltée.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Boehringer Ingelheim (Canada) Ltd./Ltée.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Boehringer Ingelheim (Canada) Ltd./Ltée. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Boehringer Ingelheim, which may influence its climate commitments and strategies. As of now, there are no documented reduction targets or climate pledges from Boehringer Ingelheim (Canada) Ltd./Ltée. This lack of specific initiatives suggests that the company may be in the early stages of developing its climate action framework or may rely on broader corporate strategies from its parent organisation. Given the absence of direct emissions data and reduction initiatives, it is essential to monitor future disclosures from Boehringer Ingelheim (Canada) Ltd./Ltée. for updates on their carbon emissions and climate commitments.
How Carbon Intensive is Boehringer Ingelheim (Canada) Ltd./Ltée.'s Industry?
How Carbon Intensive is Boehringer Ingelheim (Canada) Ltd./Ltée.'s Location?
Boehringer Ingelheim (Canada) Ltd./Ltée.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boehringer Ingelheim (Canada) Ltd./Ltée. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
